Ragnarson Tennvall G, Hjortsberg C, Bjarnason A, Gniadecki R, Heikkilä H, Jemec GB, Kragballe K, Miller IM & Svensson A.
Treatment Patterns, Treatment Satisfaction, Severity of Disease Problems, and Quality of Life in Patients with Psoriasis in Three Nordic Countries
Acta Derm Venereol. 2012 Nov 9 [Epub ahead of print]

Glenngård AH, Hjelmgren J, Thomsen PH & Tvedten T
Patient preferences and willingness-to-pay for ADHD treatment with stimulants using discrete choice experiment (DCE) in Sweden, Denmark and Norway
Nord J Psychiatry. 2012 Dec 17. [Epub ahead of print]

Anell A, Glenngård AH & Merkur S
Sweden health system review
Health Syst Transit. 2012; 14(5): 1-159

Anell A, Nylinder P & Glenngård A
Vårdval i primärvården: jämförelse av uppdrag, ersättningsprinciper och kostnadsansvar
Stockholm: Sveriges Kommuner och Landsting, 2012

Glenngård A H
Is patient satisfaction in primary care dependent on structural and organizational characteristics among providers? Findings based on data from the national patient survey in Sweden
Health Economics, Policy and Law. 2012, FirstView Article, pp 1-16

Asseburg C, Willis M, Löthgren M, Seppälä N, Hakala M & Persson U
Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection
Schizophrenia Research and Treatment. 2012; Volume 2012, Article ID 791468, 9 pages


Anderberg S & Svensson M
Vård och omsorg i hemmet för personer med multipel skleros
IHE Rapport 2012:6

Svensson J, Lundberg J, Olsson P, Stjärne P & Tennvall GR
Cost-effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis
Prim Care Respir J. 2012; 21(4): 412-8

Borg S, Näslund I, Persson U & Ödegaard K
Budget impact analysis of surgical treatment for obesity in Sweden
Scandinavian Journal of Surgery 2012; 101(3): 190–197

Lökk J, Persson U & Wainwright M
Social and Economic Benefits of Early Optimised Treatment for Parkinson´s Disease Patients - Improved Quality of Life and Greater Productivity
European Neurological Review 2012; 7(2): 113-117
Foreword by Susanna Lindvall

Frida Hjalte*, Jonas Brännström^† & Ulf-G Gerdtham*^,‡,#,¶


Read More: http://informahealthcare.com/doi/abs/10.3109/14992027.2012.690077

Hjalte F, Brännström J & Gerdtham U G
Societal costs of hearing disorders: A systematic and critical review of literature
International Journal of Audiology, 2012; 51(9): 655-662

Lindvall K, Astermark J, Björkman S, Ljung R, Steen Carlsson K, Persson S and Berntorp E
Daily dosing prophylaxis for haemophilia: a randomized crossover pilot study evaluating feasibility and efficacy
Haemophilia, 2012, publicerad online den 11 juni

Persson U, Svensson J & Pettersson B.
A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing.
Applied Health Economics and Health Policy, 2012; 10(4): 217-25

Svensson J, Ghatnekar O, Lindgren A, Lindvall O, Norrving B, Persson U & Kokaia Z
Societal Value of Stem Cell Therapy in Stroke - A Modeling Study.
Cerebrovascular Diseases, 2012; 33(6): 532-539

Thorsén F, Rosberg H-E, Steen Carlsson K & Dahlin L B.
Digital nerve injuries: Epidemiology, results, costs, and impact on daily life
Journal of Plastic Surgery and Hand Surgery, 2012; Early Online: 1–7
För tidskriftens early online » 

Ghatnekar O. & Steen Carlsson K.
Kostnader för insjuknande i stroke år 2009. En incidensbaserad studie.
Lund: IHE, 2012 (IHE Rapport 2012:2)

Steen Carlsson K. & Persson U.
Kostnader för hjärt-kärlsjukdom år 2010
Lund: IHE, 2012 (IHE Rapport 2012:1)

Ghatnekar O, Ljungberg A, Wirestrand LE, Svensson A.
Costs and quality of life for psoriatic patients at different degrees of severity in southern Sweden - a cross-sectional study.
European Journal of Dermatology. 2012 Mar-Apr;22(2):238-45.

Glenngård H Anna & Anell A.
Vad påverkar patientupplevd kvalitet i primärvården?
Stockholm : Myndigheten för vårdanalys, 2012 (Rapport 2012:1)
Rapporten kan laddas ner som pdf hos Vårdanalys.

Lundqvist A, Levin L-Å, Persson U & Steen Carlsson K
Värdet av forskning och ny medicinsk teknologi för hjärt–kärlsjukdom – en studie utifrån exemplet ischemisk hjärtsjukdom
Lund: IHE, 2012 (IHE Rapport 2012:3)

Lökk J, Borg S, Svensson J,Persson U & Ljunggren G
Drug and treatment costs in Parkinson´s disease patients in Sweden
Acta Neurologica Scandinavica 2012 Feb;125(2):142-7

Svensson, M.
Prioritering av innovativa läkemedel – erfarenheter inom ögonsjukvården i Danmark, Norge och Sverige.
Lund: IHE, 2012 (IHE Rapport 2012:4)

Norlin J M, Steen Carlsson K, Persson U & Schmitt-Egenolf M
Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients
British Journal of Dermatology. 2012; 166(4): 797-802